Showing results (141-150 of 234) with videos related to
Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.The Journal of Urology|January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.The Journal of Urology|December 6, 2017
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care OptionsMartin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJohn J Coen, Peixin Zhang, Philip J Saylor, et al.Cancer|February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancerPhillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate CancerWanling Xie, Meredith M Regan, Marc Buyse, et al.Cancer|January 3, 2014
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancerBradford S Hoppe, Jeff M Michalski, Nancy P Mendenhall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate CancerSebastian Medina, Naoto Tokuyama, Kamal Hammouda, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of LifeHiram A Gay, Martin G Sanda, Jingxia Liu, et al.European Urology|September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08Justin C Voog, Rebecca Paulus, William U Shipley, et al.Pageof 24